← All trials
NCT01765257
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2013
- Primary completion
- Dec 1, 2014
- Completion date
- Mar 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University Clermont AuvergneLead sponsor
- Centre Hospitalier Universitaire de NīmesCollaborator
- University of Picardie Jules VerneCollaborator
- Rouen Normandy UniversityCollaborator
- University of LyonCollaborator
- University Clermont AuvergneOverall official - principal investigator
- University of LilleCollaborator
- University of Caen-NormandieCollaborator
- Centre Hospitalier du Pays d'AixCollaborator
- CHU PurpanCollaborator
- LundbeckCollaborator
- University of RennesCollaborator
- University of PoitiersCollaborator
- Adolphe Rothschild Ophtalmologic FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.